Townson Sharon Insider Trades

Insider Trading History

Track insider trading activity for Townson Sharon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.6M 68,245 shares
Last Trade
Jul 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 6,000 shares
$23.31
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.73M 73,845 shares
Last Trade
Jul 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$140k 6,000 shares
$23.25
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $4.63M 197,290 shares
Last Trade
Jul 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$140k 6,000 shares
$23.25
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $4.77M 203,290 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.1k 3,000 shares
$20.71
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.59M 67,845 shares
Last Trade
Jun 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$60k 3,000 shares
$20.00
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.66M 70,845 shares
Last Trade
Jun 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.1k 3,000 shares
$20.71
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.59M 67,845 shares
Last Trade
Jun 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$57k 3,000 shares
$19.00
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $4.84M 206,290 shares
Last Trade
Jun 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.4k 3,000 shares
$18.12
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.66M 70,845 shares
Last Trade
Jun 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.4k 3,000 shares
$18.12
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $4.91M 209,290 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$118k 6,000 shares
$19.71
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.73M 73,845 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$118k 6,000 shares
$19.71
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.59M 67,845 shares
Last Trade
May 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$119k 6,000 shares
$19.87
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $1.59M 67,845 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.9k 3,155 shares
$15.17
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $3.71M 158,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 193,000 shares
$15.31
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $3.78M 161,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 161,000 shares
$7.11
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $938k 40,000 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$159k 40,000 shares
$3.98
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 28, 2024 Sale
$2.16M 517,851 shares
$4.18
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Technology Officer
Holding Value $1.84M 78,550 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 78,550 shares
$7.78
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Technology Officer
Holding Value $1.64M 70,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$939k 70,000 shares
$13.41
$23.46
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Technology Officer
Holding Value $0 0 shares
Last Trade
Jun 23, 2021 Sale
No data
No data
$23.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up